
Neoantigen Peptides for Personalized T Cell Immunotherapies in Brain Cancer
02-02-2022 / Learn how investigators at George Washington University Cancer Center leveraged synthetic peptides to activate and amplify patient-derived T cells to generate specific T cell immunotherapies for medulloblastoma.
Read More